+1 (704) 266-3234

Global And United States Lung Cancer Liquid Biops Market Size, Status And Forecast 2021-2027

Published on: Aug 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 129

Global Lung Cancer Liquid Biops Scope and Market Size
Lung Cancer Liquid Biops market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Exosomes and RNA
CTCs and ctDNA

Segment by Application
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exosomes and RNA
1.2.3 CTCs and ctDNA
1.3 Market by Application
1.3.1 Global Lung Cancer Liquid Biops Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Physicians'Office Laboratories
1.3.4 Clinical Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Liquid Biops Market Perspective (2016-2027)
2.2 Lung Cancer Liquid Biops Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Liquid Biops Industry Dynamic
2.3.1 Lung Cancer Liquid Biops Market Trends
2.3.2 Lung Cancer Liquid Biops Market Drivers
2.3.3 Lung Cancer Liquid Biops Market Challenges
2.3.4 Lung Cancer Liquid Biops Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Liquid Biops Players by Revenue
3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
3.4 Global Lung Cancer Liquid Biops Market Concentration Ratio
3.4.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2020
3.5 Lung Cancer Liquid Biops Key Players Head office and Area Served
3.6 Key Players Lung Cancer Liquid Biops Product Solution and Service
3.7 Date of Enter into Lung Cancer Liquid Biops Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biops Breakdown Data by Type
4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Liquid Biops Breakdown Data by Application
5.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Liquid Biops Market Size (2016-2027)
6.2 North America Lung Cancer Liquid Biops Market Size by Type
6.2.1 North America Lung Cancer Liquid Biops Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Liquid Biops Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Liquid Biops Market Size by Type (2016-2027)
6.3 North America Lung Cancer Liquid Biops Market Size by Application
6.3.1 North America Lung Cancer Liquid Biops Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Liquid Biops Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Liquid Biops Market Size by Application (2016-2027)
6.4 North America Lung Cancer Liquid Biops Market Size by Country
6.4.1 North America Lung Cancer Liquid Biops Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Liquid Biops Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lung Cancer Liquid Biops Market Size (2016-2027)
7.2 Europe Lung Cancer Liquid Biops Market Size by Type
7.2.1 Europe Lung Cancer Liquid Biops Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Liquid Biops Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Liquid Biops Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Liquid Biops Market Size by Application
7.3.1 Europe Lung Cancer Liquid Biops Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Liquid Biops Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Liquid Biops Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Liquid Biops Market Size by Country
7.4.1 Europe Lung Cancer Liquid Biops Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Liquid Biops Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Liquid Biops Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Liquid Biops Market Size (2016-2027)
9.2 Latin America Lung Cancer Liquid Biops Market Size by Type
9.2.1 Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Liquid Biops Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Liquid Biops Market Size by Application
9.3.1 Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Liquid Biops Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Liquid Biops Market Size by Country
9.4.1 Latin America Lung Cancer Liquid Biops Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Liquid Biops Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Liquid Biops Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Lung Cancer Liquid Biops Introduction
11.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.1.5 Biocept Recent Development
11.2 EntroGen
11.2.1 EntroGen Company Details
11.2.2 EntroGen Business Overview
11.2.3 EntroGen Lung Cancer Liquid Biops Introduction
11.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.2.5 EntroGen Recent Development
11.3 Cynvenio Biosystems
11.3.1 Cynvenio Biosystems Company Details
11.3.2 Cynvenio Biosystems Business Overview
11.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
11.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.3.5 Cynvenio Biosystems Recent Development
11.4 Exosome Diagnostics
11.4.1 Exosome Diagnostics Company Details
11.4.2 Exosome Diagnostics Business Overview
11.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
11.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.4.5 Exosome Diagnostics Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Clearbridge BioMedics
11.6.1 Clearbridge BioMedics Company Details
11.6.2 Clearbridge BioMedics Business Overview
11.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
11.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.6.5 Clearbridge BioMedics Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
11.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Agena Bioscience
11.8.1 Agena Bioscience Company Details
11.8.2 Agena Bioscience Business Overview
11.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
11.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.8.5 Agena Bioscience Recent Development
11.9 Cancer Genetics
11.9.1 Cancer Genetics Company Details
11.9.2 Cancer Genetics Business Overview
11.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
11.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.9.5 Cancer Genetics Recent Development
11.10 CellMax Life
11.10.1 CellMax Life Company Details
11.10.2 CellMax Life Business Overview
11.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
11.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.10.5 CellMax Life Recent Development
11.11 Nateras
11.11.1 Nateras Company Details
11.11.2 Nateras Business Overview
11.11.3 Nateras Lung Cancer Liquid Biops Introduction
11.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.11.5 Nateras Recent Development
11.12 MedGenome
11.12.1 MedGenome Company Details
11.12.2 MedGenome Business Overview
11.12.3 MedGenome Lung Cancer Liquid Biops Introduction
11.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.12.5 MedGenome Recent Development
11.13 OncoDNA
11.13.1 OncoDNA Company Details
11.13.2 OncoDNA Business Overview
11.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
11.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.13.5 OncoDNA Recent Development
11.14 Genomic Health
11.14.1 Genomic Health Company Details
11.14.2 Genomic Health Business Overview
11.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
11.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.14.5 Genomic Health Recent Development
11.15 Trovagene
11.15.1 Trovagene Company Details
11.15.2 Trovagene Business Overview
11.15.3 Trovagene Lung Cancer Liquid Biops Introduction
11.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.15.5 Trovagene Recent Development
11.16 Fluxion Biosciences
11.16.1 Fluxion Biosciences Company Details
11.16.2 Fluxion Biosciences Business Overview
11.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
11.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.16.5 Fluxion Biosciences Recent Development
11.17 Biodesix
11.17.1 Biodesix Company Details
11.17.2 Biodesix Business Overview
11.17.3 Biodesix Lung Cancer Liquid Biops Introduction
11.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.17.5 Biodesix Recent Development
11.18 Epic Sciences
11.18.1 Epic Sciences Company Details
11.18.2 Epic Sciences Business Overview
11.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
11.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.18.5 Epic Sciences Recent Development
11.18 Shuwen Biotech
.1 Shuwen Biotech Company Details
.2 Shuwen Biotech Business Overview
.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2016-2021)
.5 Shuwen Biotech Recent Development
11.20 Personal Genome Diagnostics
11.20.1 Personal Genome Diagnostics Company Details
11.20.2 Personal Genome Diagnostics Business Overview
11.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
11.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.20.5 Personal Genome Diagnostics Recent Development
11.21 Predicine
11.21.1 Predicine Company Details
11.21.2 Predicine Business Overview
11.21.3 Predicine Lung Cancer Liquid Biops Introduction
11.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2016-2021)
11.21.5 Predicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exosomes and RNA
Table 3. Key Players of CTCs and ctDNA
Table 4. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Lung Cancer Liquid Biops Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lung Cancer Liquid Biops Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Lung Cancer Liquid Biops Market Share by Regions (2016-2021)
Table 8. Global Lung Cancer Liquid Biops Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Lung Cancer Liquid Biops Market Share by Regions (2022-2027)
Table 10. Lung Cancer Liquid Biops Market Trends
Table 11. Lung Cancer Liquid Biops Market Drivers
Table 12. Lung Cancer Liquid Biops Market Challenges
Table 13. Lung Cancer Liquid Biops Market Restraints
Table 14. Global Lung Cancer Liquid Biops Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Lung Cancer Liquid Biops Market Share by Players (2016-2021)
Table 16. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2020)
Table 17. Ranking of Global Top Lung Cancer Liquid Biops Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biops Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lung Cancer Liquid Biops Product Solution and Service
Table 21. Date of Enter into Lung Cancer Liquid Biops Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2016-2021)
Table 25. Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Lung Cancer Liquid Biops Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2016-2021)
Table 29. Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biocept Company Details
Table 62. Biocept Business Overview
Table 63. Biocept Lung Cancer Liquid Biops Product
Table 64. Biocept Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 65. Biocept Recent Development
Table 66. EntroGen Company Details
Table 67. EntroGen Business Overview
Table 68. EntroGen Lung Cancer Liquid Biops Product
Table 69. EntroGen Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 70. EntroGen Recent Development
Table 71. Cynvenio Biosystems Company Details
Table 72. Cynvenio Biosystems Business Overview
Table 73. Cynvenio Biosystems Lung Cancer Liquid Biops Product
Table 74. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 75. Cynvenio Biosystems Recent Development
Table 76. Exosome Diagnostics Company Details
Table 77. Exosome Diagnostics Business Overview
Table 78. Exosome Diagnostics Lung Cancer Liquid Biops Product
Table 79. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 80. Exosome Diagnostics Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product
Table 84. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Clearbridge BioMedics Company Details
Table 87. Clearbridge BioMedics Business Overview
Table 88. Clearbridge BioMedics Lung Cancer Liquid Biops Product
Table 89. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 90. Clearbridge BioMedics Recent Development
Table 91. Bio-Rad Laboratories Company Details
Table 92. Bio-Rad Laboratories Business Overview
Table 93. Bio-Rad Laboratories Lung Cancer Liquid Biops Product
Table 94. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 95. Bio-Rad Laboratories Recent Development
Table 96. Agena Bioscience Company Details
Table 97. Agena Bioscience Business Overview
Table 98. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 99. Agena Bioscience Recent Development
Table 100. Cancer Genetics Company Details
Table 101. Cancer Genetics Business Overview
Table 102. Cancer Genetics Lung Cancer Liquid Biops Product
Table 103. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 104. Cancer Genetics Recent Development
Table 105. CellMax Life Company Details
Table 106. CellMax Life Business Overview
Table 107. CellMax Life Lung Cancer Liquid Biops Product
Table 108. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 109. CellMax Life Recent Development
Table 110. Nateras Company Details
Table 111. Nateras Business Overview
Table 112. Nateras Lung Cancer Liquid Biops Product
Table 113. Nateras Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 114. Nateras Recent Development
Table 115. MedGenome Company Details
Table 116. MedGenome Business Overview
Table 117. MedGenome Lung Cancer Liquid Biops Product
Table 118. MedGenome Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 119. MedGenome Recent Development
Table 120. OncoDNA Company Details
Table 121. OncoDNA Business Overview
Table 122. OncoDNA Lung Cancer Liquid Biops Product
Table 123. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 124. OncoDNA Recent Development
Table 125. Genomic Health Company Details
Table 126. Genomic Health Business Overview
Table 127. Genomic Health Lung Cancer Liquid Biops Product
Table 128. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 129. Genomic Health Recent Development
Table 130. Trovagene Company Details
Table 131. Trovagene Business Overview
Table 132. Trovagene Lung Cancer Liquid Biops Product
Table 133. Trovagene Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 134. Trovagene Recent Development
Table 135. Fluxion Biosciences Company Details
Table 136. Fluxion Biosciences Business Overview
Table 137. Fluxion Biosciences Lung Cancer Liquid Biops Product
Table 138. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 139. Fluxion Biosciences Recent Development
Table 140. Biodesix Company Details
Table 141. Biodesix Business Overview
Table 142. Biodesix Lung Cancer Liquid Biops Product
Table 143. Biodesix Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 144. Biodesix Recent Development
Table 145. Epic Sciences Company Details
Table 146. Epic Sciences Business Overview
Table 147. Epic Sciences Lung Cancer Liquid Biops Product
Table 148. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 149. Epic Sciences Recent Development
Table 150. Shuwen Biotech Company Details
Table 151. Shuwen Biotech Business Overview
Table 152. Shuwen Biotech Lung Cancer Liquid Biops Product
Table 153. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 154. Shuwen Biotech Recent Development
Table 155. Personal Genome Diagnostics Company Details
Table 156. Personal Genome Diagnostics Business Overview
Table 157. Personal Genome Diagnostics Lung Cancer Liquid Biops Product
Table 158. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 159. Personal Genome Diagnostics Recent Development
Table 160. Predicine Company Details
Table 161. Predicine Business Overview
Table 162. Predicine Lung Cancer Liquid Biops Product
Table 163. Predicine Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million)
Table 164. Predicine Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Liquid Biops Market Share by Type: 2020 VS 2027
Figure 2. Exosomes and RNA Features
Figure 3. CTCs and ctDNA Features
Figure 4. Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Physicians'Office Laboratories Case Studies
Figure 7. Clinical Diagnostic Laboratories Case Studies
Figure 8. Lung Cancer Liquid Biops Report Years Considered
Figure 9. Global Lung Cancer Liquid Biops Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Lung Cancer Liquid Biops Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lung Cancer Liquid Biops Market Share by Regions: 2020 VS 2027
Figure 12. Global Lung Cancer Liquid Biops Market Share by Regions (2022-2027)
Figure 13. Global Lung Cancer Liquid Biops Market Share by Players in 2020
Figure 14. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2020
Figure 16. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2016-2021)
Figure 17. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2022-2027)
Figure 18. North America Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Lung Cancer Liquid Biops Market Share by Type (2016-2027)
Figure 20. North America Lung Cancer Liquid Biops Market Share by Application (2016-2027)
Figure 21. North America Lung Cancer Liquid Biops Market Share by Country (2016-2027)
Figure 22. United States Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lung Cancer Liquid Biops Market Share by Type (2016-2027)
Figure 26. Europe Lung Cancer Liquid Biops Market Share by Application (2016-2027)
Figure 27. Europe Lung Cancer Liquid Biops Market Share by Country (2016-2027)
Figure 28. Germany Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lung Cancer Liquid Biops Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Lung Cancer Liquid Biops Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2016-2027)
Figure 38. China Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lung Cancer Liquid Biops Market Share by Type (2016-2027)
Figure 46. Latin America Lung Cancer Liquid Biops Market Share by Application (2016-2027)
Figure 47. Latin America Lung Cancer Liquid Biops Market Share by Country (2016-2027)
Figure 48. Mexico Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lung Cancer Liquid Biops Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Lung Cancer Liquid Biops Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Lung Cancer Liquid Biops Market Share by Country (2016-2027)
Figure 54. Turkey Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 58. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 59. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 60. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 62. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 64. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 65. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 66. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 67. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 68. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 69. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 70. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 71. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 72. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 73. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 74. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 75. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 76. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 77. Predicine Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.